North America Targeted Protein Degradation Market Size & Outlook
The targeted protein degradation market in North America is expected to reach a projected revenue of US$ 655,151.7 million by 2030. A compound annual growth rate of 20.1% is expected of North America targeted protein degradation market from 2024 to 2030.
Revenue, 2023 (US$M)
$182,289.5
Forecast, 2030 (US$M)
$655,151.7
CAGR, 2024 - 2030
20.1%
Report Coverage
North America
North America targeted protein degradation market, 2018-2030 (US$M)
North America targeted protein degradation market highlights
- The North America targeted protein degradation market generated a revenue of USD 182,289.5 million in 2023.
- The market is expected to grow at a CAGR of 20.1% from 2024 to 2030.
- In terms of segment, protac was the largest revenue generating type in 2023.
- PROTAC is the most lucrative type segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2023 | USD 182,289.5 million |
| Market revenue in 2030 | USD 655,151.7 million |
| Growth rate | 20.1% (CAGR from 2023 to 2030) |
| Largest segment | Protac |
| Fastest growing segment | PROTAC |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PROTAC |
| Key market players worldwide | Thermo Fisher Scientific Inc, Bio-Techne Corp, Promega, Merck KGaA, BPS Bioscience Inc., Bayer AG, BroadPharm, BOC Sciences |
Other key industry trends
- In terms of revenue, North America region accounted for 40.3% of the global targeted protein degradation market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 458,650.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Targeted Protein Degradation Market Scope
Targeted protein degradation market segmentation & scope
Application
Drug Discovery
Therapy Development
Cancer
Neurology
Infectious Diseases
Cardiovascular Diseases
Others
End Use
Pharmaceutical & Biotechnology Companies
Hospitals & Clinical Laboratories
Academic & Research Institutes
Other End-use
Countries
U.S.
Canada
Mexico
Denmark
France
Germany
Italy
Spain
Sweden
UK
Norway
Brazil
Argentina
Australia
China
India
Japan
South Korea
Thailand
UAE
South Africa
Saudi Arabia
Kuwait
Targeted Protein Degradation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America targeted protein degradation market
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
